The role of myeloid-derived suppressor cells in lung cancer
Jeiciane Gleicilene Silva, Ruan de Moura Fabricio de Siqueira, Rone Cardoso Magalhães, Caio Fernandes Silva, Anthonio Lucca Antunes Camargos, Valéria de Lima Kaminski · 2026
Read The role of myeloid-derived suppressor cells in lung cancer by Jeiciane Gleicilene Silva, Ruan de Moura Fabricio de Siqueira, Rone Cardoso Magalhães, Caio Fernandes Silva, Anthonio Lucca Antunes Camargos, Valéria de Lima Kaminski (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7212071566.txt.
Description
Jeiciane Gleicilene Silva leads a team reviewing one class of immune cells and their role in lung cancer. The cells are myeloid-derived suppressor cells. As their name says, they hold down the immune response. Lung cancer still ranks among the top causes of cancer death in the world. Two forces drive its growth: the tumor hides from immune attack, and the tissue stays inflamed for years.
The team read recent studies on what these cells do in lung tumors. They tracked how the cells act, and what that means for care. A tumor that can switch off its attackers gains room to grow. It also gains cover against drugs that rely on the immune system. Work of this kind maps a target that new care may one day strike. It also warns why some strong drugs fail in the lung.
Catalog record
| CREATOR | Jeiciane Gleicilene Silva, Ruan de Moura Fabricio de Siqueira, Rone Cardoso Magalhães, Caio Fernandes Silva, Anthonio Lucca Antunes Camargos, Valéria de Lima Kaminski |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Research Society and Development |